Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)

Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)

Conditions: Mild Autonomous Cortisol Secretion (MACS)
Interventions: Drug: Osilodrostat (Isturisa)
Sponsors: Johns Hopkins University
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 26, 2025Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments